Schroder Investment Management Group grew its position in Colgate-Palmolive (NYSE:CL) by 81.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,737,556 shares of the company’s stock after purchasing an additional 778,350 shares during the quarter. Schroder Investment Management Group’s holdings in Colgate-Palmolive were worth $131,100,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in CL. Beach Investment Management LLC. acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at $3,954,000. Willingdon Wealth Management raised its stake in Colgate-Palmolive by 1.1% during the 2nd quarter. Willingdon Wealth Management now owns 28,048 shares of the company’s stock worth $2,079,000 after acquiring an additional 312 shares in the last quarter. Airain ltd acquired a new stake in Colgate-Palmolive during the 2nd quarter worth $653,000. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in Colgate-Palmolive by 17.8% during the 2nd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 167,306 shares of the company’s stock worth $12,402,000 after acquiring an additional 25,241 shares in the last quarter. Finally, BDO Wealth Advisors LLC acquired a new stake in Colgate-Palmolive during the 2nd quarter worth $266,000. Institutional investors and hedge funds own 71.52% of the company’s stock.
Several equities research analysts recently commented on CL shares. Citigroup cut their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, November 1st. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a research note on Tuesday, December 19th. Finally, Deutsche Bank started coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $77.91.
Colgate-Palmolive (NYSE:CL) opened at $70.30 on Friday. Colgate-Palmolive has a 52-week low of $68.19 and a 52-week high of $77.91. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The stock has a market cap of $61,535.49, a price-to-earnings ratio of 30.83, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same period last year, the firm posted $0.75 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.6% on a year-over-year basis. equities analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend was Monday, January 22nd. Colgate-Palmolive’s payout ratio is currently 70.18%.
In other Colgate-Palmolive news, CFO Dennis J. Hickey sold 5,651 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $70.18, for a total transaction of $396,587.18. Following the transaction, the chief financial officer now directly owns 413,221 shares of the company’s stock, valued at approximately $28,999,849.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total transaction of $539,702.50. Following the transaction, the insider now directly owns 38,691 shares in the company, valued at $2,831,407.38. The disclosure for this sale can be found here. Insiders have sold a total of 463,082 shares of company stock worth $32,983,130 over the last three months. 1.02% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://transcriptdaily.com/2018/02/25/schroder-investment-management-group-has-131-10-million-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.